Targeting oxidative stress, apoptosis, and autophagy by galangin mitigates cadmium-induced renal damage: Role of SIRT1/Nrf2 and AMPK/mTOR pathways

Galangin, a bioactive flavonoid with remarkable antioxidant and anti-apoptotic actions, has demonstrated promising amelioration of experimental hepatotoxicity, cardiomyopathy, and colitis. Yet, its impact on cadmium-induced renal injury has not been explored. Herein, we aimed at exploring the potent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 2022-02, Vol.291, p.120300-120300, Article 120300
Hauptverfasser: Arab, Hany H., Ashour, Ahmed M., Eid, Ahmed H., Arafa, El-Shaimaa A., Al Khabbaz, Hana J., Abd El-Aal, Sarah A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 120300
container_issue
container_start_page 120300
container_title Life sciences (1973)
container_volume 291
creator Arab, Hany H.
Ashour, Ahmed M.
Eid, Ahmed H.
Arafa, El-Shaimaa A.
Al Khabbaz, Hana J.
Abd El-Aal, Sarah A.
description Galangin, a bioactive flavonoid with remarkable antioxidant and anti-apoptotic actions, has demonstrated promising amelioration of experimental hepatotoxicity, cardiomyopathy, and colitis. Yet, its impact on cadmium-induced renal injury has not been explored. Herein, we aimed at exploring the potential of galangin to attenuate cadmium-induced nephrotoxicity in rats, focusing on oxidative stress, apoptosis, and autophagy. Cadmium chloride (5 mg/kg/day) and galangin (15 mg/kg/day) were received by oral gavage and the kidney tissues were inspected using ELISA, biochemical measurements, histology, and immunohistochemistry. Galangin attenuated cadmium-induced renal damage by diminishing the histopathological alterations alongside KIM-1, BUN, and creatinine. At the molecular level, galangin attenuated the oxidative insult by significantly lowering the lipid peroxides and NOX-1 and augmenting GSH and GPx antioxidants. It also activated the cytoprotective SIRT1/Nrf2/HO-1 pathway by significantly upregulating the protein expression of SIRT1, Nrf2, and HO-1. Consistently, galangin suppressed renal apoptotic cell death by significantly lowering the protein expression of Bax and cytochrome C and activity of caspase-3 alongside upregulating the protein expression of the anti-apoptotic Bcl-2. Additionally, galangin activated the impaired autophagy flux as seen by diminishing the accumulation of SQSTM1/p62 and increasing the protein expression of Beclin 1. Meanwhile, galangin stimulated the autophagy-linked AMPK/mTOR pathway by significantly increasing the p-AMPK/total AMPK and lowering p-mTOR/total mTOR ratios. Galangin mitigated cadmium-induced nephrotoxicity thanks to its promising antioxidant, anti-apoptotic, and pro-autophagic effects. In perspective, galangin stimulated the SIRT1/Nrf2/HO-1 and AMPK/mTOR pathways. Hence, it may act as a complementary tool for the management of cadmium-induced renal injury. •Galangin improved the kidney function markers and histopathologic alterations in rats.•Galangin curtailed oxidative perturbations and enhanced renal antioxidants defenses.•Galangin activated the cytoprotective SIRT1/Nrf2/HO-1 pathway•Galangin dampened renal pro-apoptotic markers (caspase-3 activity and Bax/Bcl-2 ratio)•Galangin activated the renal autophagy flux and AMPK/mTOR pathway.
doi_str_mv 10.1016/j.lfs.2021.120300
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2618520110</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002432052101287X</els_id><sourcerecordid>2628816491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-476cc147f66605e5a40de6dc7ea2c56c63ac1024c3baed113bf7075a05c16eaf3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhiMEotvCD-CCLHHh0Ox6nNjZhVNV8VFRKFqWszVrT1KvkjjYTmH_Br-YLFs4cOA0c3jmleZ9suwZ8DlwUIvdvK3jXHABcxC84PxBNoNltcq5KuBhNuNclHkhuDzJTmPccc6lrIrH2UlRrlYrADnLfm4wNJRc3zD_w1lM7o5YTIFiPGc4-CH56A5rbxmOyQ-32OzZds8abLFvXM86l1yDiSIzaDs3drnr7WjIskA9tsxihw29YmvfEvM1-3K13sDiU6jF79CLj58_LLrNzZoNmG6_4z4-yR7V2EZ6ej_Psq9v32wu3-fXN--uLi-uc1OWVcrLShkDZVUrpbgkiSW3pKypCIWRyqgCDUwFmGKLZAGKbV3xSiKXBhRhXZxlL4-5Q_DfRopJdy4aaqe_yI9RCwVLKTgAn9AX_6A7P4bpuwMllktQ5QomCo6UCT7GQLUegusw7DVwfRCmd3oSpg_C9FHYdPP8PnncdmT_XvwxNAGvjwBNVdw5CjoaR_3Urwtkkrbe_Sf-F8liphc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2628816491</pqid></control><display><type>article</type><title>Targeting oxidative stress, apoptosis, and autophagy by galangin mitigates cadmium-induced renal damage: Role of SIRT1/Nrf2 and AMPK/mTOR pathways</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Arab, Hany H. ; Ashour, Ahmed M. ; Eid, Ahmed H. ; Arafa, El-Shaimaa A. ; Al Khabbaz, Hana J. ; Abd El-Aal, Sarah A.</creator><creatorcontrib>Arab, Hany H. ; Ashour, Ahmed M. ; Eid, Ahmed H. ; Arafa, El-Shaimaa A. ; Al Khabbaz, Hana J. ; Abd El-Aal, Sarah A.</creatorcontrib><description>Galangin, a bioactive flavonoid with remarkable antioxidant and anti-apoptotic actions, has demonstrated promising amelioration of experimental hepatotoxicity, cardiomyopathy, and colitis. Yet, its impact on cadmium-induced renal injury has not been explored. Herein, we aimed at exploring the potential of galangin to attenuate cadmium-induced nephrotoxicity in rats, focusing on oxidative stress, apoptosis, and autophagy. Cadmium chloride (5 mg/kg/day) and galangin (15 mg/kg/day) were received by oral gavage and the kidney tissues were inspected using ELISA, biochemical measurements, histology, and immunohistochemistry. Galangin attenuated cadmium-induced renal damage by diminishing the histopathological alterations alongside KIM-1, BUN, and creatinine. At the molecular level, galangin attenuated the oxidative insult by significantly lowering the lipid peroxides and NOX-1 and augmenting GSH and GPx antioxidants. It also activated the cytoprotective SIRT1/Nrf2/HO-1 pathway by significantly upregulating the protein expression of SIRT1, Nrf2, and HO-1. Consistently, galangin suppressed renal apoptotic cell death by significantly lowering the protein expression of Bax and cytochrome C and activity of caspase-3 alongside upregulating the protein expression of the anti-apoptotic Bcl-2. Additionally, galangin activated the impaired autophagy flux as seen by diminishing the accumulation of SQSTM1/p62 and increasing the protein expression of Beclin 1. Meanwhile, galangin stimulated the autophagy-linked AMPK/mTOR pathway by significantly increasing the p-AMPK/total AMPK and lowering p-mTOR/total mTOR ratios. Galangin mitigated cadmium-induced nephrotoxicity thanks to its promising antioxidant, anti-apoptotic, and pro-autophagic effects. In perspective, galangin stimulated the SIRT1/Nrf2/HO-1 and AMPK/mTOR pathways. Hence, it may act as a complementary tool for the management of cadmium-induced renal injury. •Galangin improved the kidney function markers and histopathologic alterations in rats.•Galangin curtailed oxidative perturbations and enhanced renal antioxidants defenses.•Galangin activated the cytoprotective SIRT1/Nrf2/HO-1 pathway•Galangin dampened renal pro-apoptotic markers (caspase-3 activity and Bax/Bcl-2 ratio)•Galangin activated the renal autophagy flux and AMPK/mTOR pathway.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2021.120300</identifier><identifier>PMID: 34999115</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Adenylate Kinase - metabolism ; AMP-Activated Protein Kinases - metabolism ; Animals ; Antioxidants ; Apoptosis ; Apoptosis - drug effects ; Attenuation ; Autophagy ; BAX protein ; Bcl-2 protein ; Cadmium ; Cadmium - adverse effects ; Cadmium - pharmacology ; Cadmium chloride ; Cardiomyopathy ; Caspase-3 ; Cell death ; Colitis ; Creatinine ; Cytochrome ; Cytochrome c ; Cytochromes ; Damage ; Enzyme-linked immunosorbent assay ; Flavonoids ; Flavonoids - metabolism ; Flavonoids - pharmacology ; Galangin ; Hepatotoxicity ; Histology ; Immunohistochemistry ; Kidney - pathology ; Kidney Diseases - chemically induced ; Kidney Diseases - drug therapy ; Kidney Diseases - metabolism ; Kidneys ; Lipids ; Male ; NF-E2-Related Factor 2 - metabolism ; Oxidative stress ; Oxidative Stress - drug effects ; Peroxides ; Protein expression ; Proteins ; Rats ; Rats, Wistar ; Signal Transduction - drug effects ; SIRT1 protein ; Sirtuin 1 - metabolism ; TOR protein ; TOR Serine-Threonine Kinases - metabolism</subject><ispartof>Life sciences (1973), 2022-02, Vol.291, p.120300-120300, Article 120300</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier BV Feb 15, 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-476cc147f66605e5a40de6dc7ea2c56c63ac1024c3baed113bf7075a05c16eaf3</citedby><cites>FETCH-LOGICAL-c447t-476cc147f66605e5a40de6dc7ea2c56c63ac1024c3baed113bf7075a05c16eaf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S002432052101287X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34999115$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arab, Hany H.</creatorcontrib><creatorcontrib>Ashour, Ahmed M.</creatorcontrib><creatorcontrib>Eid, Ahmed H.</creatorcontrib><creatorcontrib>Arafa, El-Shaimaa A.</creatorcontrib><creatorcontrib>Al Khabbaz, Hana J.</creatorcontrib><creatorcontrib>Abd El-Aal, Sarah A.</creatorcontrib><title>Targeting oxidative stress, apoptosis, and autophagy by galangin mitigates cadmium-induced renal damage: Role of SIRT1/Nrf2 and AMPK/mTOR pathways</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Galangin, a bioactive flavonoid with remarkable antioxidant and anti-apoptotic actions, has demonstrated promising amelioration of experimental hepatotoxicity, cardiomyopathy, and colitis. Yet, its impact on cadmium-induced renal injury has not been explored. Herein, we aimed at exploring the potential of galangin to attenuate cadmium-induced nephrotoxicity in rats, focusing on oxidative stress, apoptosis, and autophagy. Cadmium chloride (5 mg/kg/day) and galangin (15 mg/kg/day) were received by oral gavage and the kidney tissues were inspected using ELISA, biochemical measurements, histology, and immunohistochemistry. Galangin attenuated cadmium-induced renal damage by diminishing the histopathological alterations alongside KIM-1, BUN, and creatinine. At the molecular level, galangin attenuated the oxidative insult by significantly lowering the lipid peroxides and NOX-1 and augmenting GSH and GPx antioxidants. It also activated the cytoprotective SIRT1/Nrf2/HO-1 pathway by significantly upregulating the protein expression of SIRT1, Nrf2, and HO-1. Consistently, galangin suppressed renal apoptotic cell death by significantly lowering the protein expression of Bax and cytochrome C and activity of caspase-3 alongside upregulating the protein expression of the anti-apoptotic Bcl-2. Additionally, galangin activated the impaired autophagy flux as seen by diminishing the accumulation of SQSTM1/p62 and increasing the protein expression of Beclin 1. Meanwhile, galangin stimulated the autophagy-linked AMPK/mTOR pathway by significantly increasing the p-AMPK/total AMPK and lowering p-mTOR/total mTOR ratios. Galangin mitigated cadmium-induced nephrotoxicity thanks to its promising antioxidant, anti-apoptotic, and pro-autophagic effects. In perspective, galangin stimulated the SIRT1/Nrf2/HO-1 and AMPK/mTOR pathways. Hence, it may act as a complementary tool for the management of cadmium-induced renal injury. •Galangin improved the kidney function markers and histopathologic alterations in rats.•Galangin curtailed oxidative perturbations and enhanced renal antioxidants defenses.•Galangin activated the cytoprotective SIRT1/Nrf2/HO-1 pathway•Galangin dampened renal pro-apoptotic markers (caspase-3 activity and Bax/Bcl-2 ratio)•Galangin activated the renal autophagy flux and AMPK/mTOR pathway.</description><subject>Adenylate Kinase - metabolism</subject><subject>AMP-Activated Protein Kinases - metabolism</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Attenuation</subject><subject>Autophagy</subject><subject>BAX protein</subject><subject>Bcl-2 protein</subject><subject>Cadmium</subject><subject>Cadmium - adverse effects</subject><subject>Cadmium - pharmacology</subject><subject>Cadmium chloride</subject><subject>Cardiomyopathy</subject><subject>Caspase-3</subject><subject>Cell death</subject><subject>Colitis</subject><subject>Creatinine</subject><subject>Cytochrome</subject><subject>Cytochrome c</subject><subject>Cytochromes</subject><subject>Damage</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Flavonoids</subject><subject>Flavonoids - metabolism</subject><subject>Flavonoids - pharmacology</subject><subject>Galangin</subject><subject>Hepatotoxicity</subject><subject>Histology</subject><subject>Immunohistochemistry</subject><subject>Kidney - pathology</subject><subject>Kidney Diseases - chemically induced</subject><subject>Kidney Diseases - drug therapy</subject><subject>Kidney Diseases - metabolism</subject><subject>Kidneys</subject><subject>Lipids</subject><subject>Male</subject><subject>NF-E2-Related Factor 2 - metabolism</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Peroxides</subject><subject>Protein expression</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Signal Transduction - drug effects</subject><subject>SIRT1 protein</subject><subject>Sirtuin 1 - metabolism</subject><subject>TOR protein</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhiMEotvCD-CCLHHh0Ox6nNjZhVNV8VFRKFqWszVrT1KvkjjYTmH_Br-YLFs4cOA0c3jmleZ9suwZ8DlwUIvdvK3jXHABcxC84PxBNoNltcq5KuBhNuNclHkhuDzJTmPccc6lrIrH2UlRrlYrADnLfm4wNJRc3zD_w1lM7o5YTIFiPGc4-CH56A5rbxmOyQ-32OzZds8abLFvXM86l1yDiSIzaDs3drnr7WjIskA9tsxihw29YmvfEvM1-3K13sDiU6jF79CLj58_LLrNzZoNmG6_4z4-yR7V2EZ6ej_Psq9v32wu3-fXN--uLi-uc1OWVcrLShkDZVUrpbgkiSW3pKypCIWRyqgCDUwFmGKLZAGKbV3xSiKXBhRhXZxlL4-5Q_DfRopJdy4aaqe_yI9RCwVLKTgAn9AX_6A7P4bpuwMllktQ5QomCo6UCT7GQLUegusw7DVwfRCmd3oSpg_C9FHYdPP8PnncdmT_XvwxNAGvjwBNVdw5CjoaR_3Urwtkkrbe_Sf-F8liphc</recordid><startdate>20220215</startdate><enddate>20220215</enddate><creator>Arab, Hany H.</creator><creator>Ashour, Ahmed M.</creator><creator>Eid, Ahmed H.</creator><creator>Arafa, El-Shaimaa A.</creator><creator>Al Khabbaz, Hana J.</creator><creator>Abd El-Aal, Sarah A.</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20220215</creationdate><title>Targeting oxidative stress, apoptosis, and autophagy by galangin mitigates cadmium-induced renal damage: Role of SIRT1/Nrf2 and AMPK/mTOR pathways</title><author>Arab, Hany H. ; Ashour, Ahmed M. ; Eid, Ahmed H. ; Arafa, El-Shaimaa A. ; Al Khabbaz, Hana J. ; Abd El-Aal, Sarah A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-476cc147f66605e5a40de6dc7ea2c56c63ac1024c3baed113bf7075a05c16eaf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adenylate Kinase - metabolism</topic><topic>AMP-Activated Protein Kinases - metabolism</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Attenuation</topic><topic>Autophagy</topic><topic>BAX protein</topic><topic>Bcl-2 protein</topic><topic>Cadmium</topic><topic>Cadmium - adverse effects</topic><topic>Cadmium - pharmacology</topic><topic>Cadmium chloride</topic><topic>Cardiomyopathy</topic><topic>Caspase-3</topic><topic>Cell death</topic><topic>Colitis</topic><topic>Creatinine</topic><topic>Cytochrome</topic><topic>Cytochrome c</topic><topic>Cytochromes</topic><topic>Damage</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Flavonoids</topic><topic>Flavonoids - metabolism</topic><topic>Flavonoids - pharmacology</topic><topic>Galangin</topic><topic>Hepatotoxicity</topic><topic>Histology</topic><topic>Immunohistochemistry</topic><topic>Kidney - pathology</topic><topic>Kidney Diseases - chemically induced</topic><topic>Kidney Diseases - drug therapy</topic><topic>Kidney Diseases - metabolism</topic><topic>Kidneys</topic><topic>Lipids</topic><topic>Male</topic><topic>NF-E2-Related Factor 2 - metabolism</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Peroxides</topic><topic>Protein expression</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Signal Transduction - drug effects</topic><topic>SIRT1 protein</topic><topic>Sirtuin 1 - metabolism</topic><topic>TOR protein</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arab, Hany H.</creatorcontrib><creatorcontrib>Ashour, Ahmed M.</creatorcontrib><creatorcontrib>Eid, Ahmed H.</creatorcontrib><creatorcontrib>Arafa, El-Shaimaa A.</creatorcontrib><creatorcontrib>Al Khabbaz, Hana J.</creatorcontrib><creatorcontrib>Abd El-Aal, Sarah A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arab, Hany H.</au><au>Ashour, Ahmed M.</au><au>Eid, Ahmed H.</au><au>Arafa, El-Shaimaa A.</au><au>Al Khabbaz, Hana J.</au><au>Abd El-Aal, Sarah A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting oxidative stress, apoptosis, and autophagy by galangin mitigates cadmium-induced renal damage: Role of SIRT1/Nrf2 and AMPK/mTOR pathways</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2022-02-15</date><risdate>2022</risdate><volume>291</volume><spage>120300</spage><epage>120300</epage><pages>120300-120300</pages><artnum>120300</artnum><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Galangin, a bioactive flavonoid with remarkable antioxidant and anti-apoptotic actions, has demonstrated promising amelioration of experimental hepatotoxicity, cardiomyopathy, and colitis. Yet, its impact on cadmium-induced renal injury has not been explored. Herein, we aimed at exploring the potential of galangin to attenuate cadmium-induced nephrotoxicity in rats, focusing on oxidative stress, apoptosis, and autophagy. Cadmium chloride (5 mg/kg/day) and galangin (15 mg/kg/day) were received by oral gavage and the kidney tissues were inspected using ELISA, biochemical measurements, histology, and immunohistochemistry. Galangin attenuated cadmium-induced renal damage by diminishing the histopathological alterations alongside KIM-1, BUN, and creatinine. At the molecular level, galangin attenuated the oxidative insult by significantly lowering the lipid peroxides and NOX-1 and augmenting GSH and GPx antioxidants. It also activated the cytoprotective SIRT1/Nrf2/HO-1 pathway by significantly upregulating the protein expression of SIRT1, Nrf2, and HO-1. Consistently, galangin suppressed renal apoptotic cell death by significantly lowering the protein expression of Bax and cytochrome C and activity of caspase-3 alongside upregulating the protein expression of the anti-apoptotic Bcl-2. Additionally, galangin activated the impaired autophagy flux as seen by diminishing the accumulation of SQSTM1/p62 and increasing the protein expression of Beclin 1. Meanwhile, galangin stimulated the autophagy-linked AMPK/mTOR pathway by significantly increasing the p-AMPK/total AMPK and lowering p-mTOR/total mTOR ratios. Galangin mitigated cadmium-induced nephrotoxicity thanks to its promising antioxidant, anti-apoptotic, and pro-autophagic effects. In perspective, galangin stimulated the SIRT1/Nrf2/HO-1 and AMPK/mTOR pathways. Hence, it may act as a complementary tool for the management of cadmium-induced renal injury. •Galangin improved the kidney function markers and histopathologic alterations in rats.•Galangin curtailed oxidative perturbations and enhanced renal antioxidants defenses.•Galangin activated the cytoprotective SIRT1/Nrf2/HO-1 pathway•Galangin dampened renal pro-apoptotic markers (caspase-3 activity and Bax/Bcl-2 ratio)•Galangin activated the renal autophagy flux and AMPK/mTOR pathway.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>34999115</pmid><doi>10.1016/j.lfs.2021.120300</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2022-02, Vol.291, p.120300-120300, Article 120300
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_2618520110
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adenylate Kinase - metabolism
AMP-Activated Protein Kinases - metabolism
Animals
Antioxidants
Apoptosis
Apoptosis - drug effects
Attenuation
Autophagy
BAX protein
Bcl-2 protein
Cadmium
Cadmium - adverse effects
Cadmium - pharmacology
Cadmium chloride
Cardiomyopathy
Caspase-3
Cell death
Colitis
Creatinine
Cytochrome
Cytochrome c
Cytochromes
Damage
Enzyme-linked immunosorbent assay
Flavonoids
Flavonoids - metabolism
Flavonoids - pharmacology
Galangin
Hepatotoxicity
Histology
Immunohistochemistry
Kidney - pathology
Kidney Diseases - chemically induced
Kidney Diseases - drug therapy
Kidney Diseases - metabolism
Kidneys
Lipids
Male
NF-E2-Related Factor 2 - metabolism
Oxidative stress
Oxidative Stress - drug effects
Peroxides
Protein expression
Proteins
Rats
Rats, Wistar
Signal Transduction - drug effects
SIRT1 protein
Sirtuin 1 - metabolism
TOR protein
TOR Serine-Threonine Kinases - metabolism
title Targeting oxidative stress, apoptosis, and autophagy by galangin mitigates cadmium-induced renal damage: Role of SIRT1/Nrf2 and AMPK/mTOR pathways
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T18%3A01%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20oxidative%20stress,%20apoptosis,%20and%20autophagy%20by%20galangin%20mitigates%20cadmium-induced%20renal%20damage:%20Role%20of%20SIRT1/Nrf2%20and%20AMPK/mTOR%20pathways&rft.jtitle=Life%20sciences%20(1973)&rft.au=Arab,%20Hany%20H.&rft.date=2022-02-15&rft.volume=291&rft.spage=120300&rft.epage=120300&rft.pages=120300-120300&rft.artnum=120300&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2021.120300&rft_dat=%3Cproquest_cross%3E2628816491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2628816491&rft_id=info:pmid/34999115&rft_els_id=S002432052101287X&rfr_iscdi=true